CN103142735B - Traditional Chinese medicine oral liquid for treating duck virus hepatitis - Google Patents
Traditional Chinese medicine oral liquid for treating duck virus hepatitis Download PDFInfo
- Publication number
- CN103142735B CN103142735B CN201310074388.5A CN201310074388A CN103142735B CN 103142735 B CN103142735 B CN 103142735B CN 201310074388 A CN201310074388 A CN 201310074388A CN 103142735 B CN103142735 B CN 103142735B
- Authority
- CN
- China
- Prior art keywords
- radix
- medicated powder
- medicinal liquid
- liquid
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a traditional Chinese medicine oral liquid for treating duck virus hepatitis, which comprises 8-12g of Isatis indigotica Fort, 8-12g of safflower seed, 8-12g of oriental wormwood, 8-12g of radix astragali, 8-12g of dried orange peel, 3-7g of herba schizonepetae, 3-7g of Zornia gibbosa, 3-7g of sagina subulata, 3-7g of radix bupleuri, 3-7g of radix sileris, 3-7g of gardenia, 3-7g of honeysuckle flower, 3-7g of Fructus Forsythiae, 3-7g of uncaria and 3-7g of hay. The preparation technique comprises the following steps: (1) sorting; (2) superfine grinding; (3) soaking; (4) liquor extraction; (5) microwave extraction; (6) filtering; (7) preservative addition; and (8) packaging. The traditional Chinese medicine oral liquid disclosed by the invention has the advantages of favorable effect for treating duck virus hepatitis, low residue and high biosafety.
Description
Technical field
The present invention relates to a kind of Chinese medicine oral liquid for the treatment of duck viral hepatitis, especially a kind of Chinese medicine oral liquid for the treatment of Duck Hepatitis Virus.
Background technology
At present, be mainly to use vaccine prevention to duck viral hepatitis (DHV), duck hepatitis B virus infection.Immunity is with vaccine often because preservation and improper use cause immuning failure, and some area causes popular because immune density is not high, and provisions duck industry causes serious economic loss.Use hyper-immune serum and monoclonal antibody again because of resource scarcity, expensive, cause practical application to be restricted.For addressing the above problem, select compound Chinese medicinal herb extract to prevent and treat duck viral hepatitis, virus function is had to many targets, obtain good effect.Chinese medicine oral liquid low-residual or noresidue, biological safety is good, easy to use.Therefore, research one is treated the eutherapeutic Chinese medicine oral liquid of duck viral hepatitis (DHV), is the current technical issues that need to address.
Summary of the invention
Technical problem to be solved by this invention be to provide a kind of treat duck viral hepatitis effective, can improve serum antibody titer, to virus function have many targets, low-residual, biological safety good, easy to use Chinese medicine oral liquid.
The technical scheme that the present invention solves its technical problem is:
Treat a Chinese medicine oral liquid for duck viral hepatitis, its constituent is: Radix Isatidis 8～12g, Fructus Carthami tinctorii 8～12g, Herba Artemisiae Scopariae 8～12g, the Radix Astragali 8～12g, Pericarpium Citri Reticulatae 8～12g, Herba Schizonepetae 3～7g, Zornia diphylla (Linn.) Pers. 3～7g, Herba Phyllanthi Urinariae 3～7g, Radix Bupleuri 3～7g, Radix Saposhnikoviae 3～7g, Fructus Gardeniae 3～7g, Flos Lonicerae 3～7g, Fructus Forsythiae 3～7g, Ramulus Uncariae Cum Uncis 3～7g, Radix Glycyrrhizae 3～7g.Its processing technology is: 1. sorting, and 2. micronizing, 3. soaks, and 4. medicinal liquid extracts, and 6. 5. microwave extraction filters, and 7. adds antiseptic, 8. subpackage.
The technical scheme that the present invention solves its technical problem can also be:
Its constituent of the present invention is: Radix Isatidis 10g, Fructus Carthami tinctorii 10g, Herba Artemisiae Scopariae 10g, Radix Astragali 10g, Pericarpium Citri Reticulatae 10g, Herba Schizonepetae 5g, Zornia diphylla (Linn.) Pers. 5g, Herba Phyllanthi Urinariae 5g, Radix Bupleuri 5g, Radix Saposhnikoviae 5g, Fructus Gardeniae 5g, Flos Lonicerae 5g, Fructus Forsythiae 5g, Ramulus Uncariae Cum Uncis 5g, Radix Glycyrrhizae 5g.
Sorting of the present invention, remove the impurity in each component, described micronizing, respectively above-mentioned each component is weighed and mix after be ground into 200 object fine powders, described immersion, under the clear water room temperature of the medicated powder that is about to crush by 5 times of medicated powder weight, soak 3 hours, described medicinal liquid extracts, from soaked medicine liquid mixture by medicated powder residue and separating liquid medicine, leave and take medicinal liquid for subsequent use, described microwave extraction, the medicinal liquid that is about to extract is condensed into medicinal liquid by microwave concentration technique the concentrated solution of 1 times of former medicated powder weight.
The present invention under the clear water room temperature by 5 times of former medicated powder weight soaks isolated medicated powder residue after soaking 3 hours again, and then from through secondary soak medicine liquid mixture by medicated powder residue and separating liquid medicine, leave and take medicinal liquid, secondary is left and taken to medicinal liquid and isolated medicinal liquid for the first time and more mixed medicinal liquid is condensed into after mixing the concentrated solution of 1 times of former medicated powder weight.
The invention has the beneficial effects as follows:
1, there is non-specific immunity;
2, can improve serum antibody titer;
3, residual low or noresidue, biological safety is good;
4, Chinese herbal medicine resource is abundant, cost is low, easy to use.
Using method of the present invention is:
The present invention is diluted with clear water in 1:100 ratio, and consumption is the subnormal amount of drinking water of duck one, once-a-day, within 5th～7, can cure.
Clinical testing data of the present invention is as follows: cure rate 96%, effective percentage 100%.
Illustrate beneficial effect of the present invention below by several routine model cases:
Embodiment 1: 10,000 meat-type duck generation duck viral hepatitiss of Tangshan one meat-type duck factory, with Chinese medicine oral liquid treatment after 2 days symptom obviously alleviate, recovery from illness afterwards in 5 days, cure rate 96%, effective percentage 100%.
Embodiment 2: 8,000 meat-type duck generation duck viral hepatitiss of Changyi, Shandong one meat-type duck factory, with Chinese medicine oral liquid treatment after 36 hours symptom alleviate, recovery from illness afterwards in 4 days, cure rate 97%, effective percentage 100%.
Embodiment 3: 10,000 meat-type duck generation duck viral hepatitiss of Ganyu, Jiangsu one meat-type duck factory, with Chinese medicine oral liquid treatment after 2 days symptom obviously alleviate, recovery from illness afterwards in 5 days, cure rate 96%, effective percentage 100%.
Detailed description of the invention
Enumerate 10 specific embodiments of the present invention below by the mode of list, whole compositions are market and directly buy, its processing technology is: 1. sorting, remove the impurity in each component, 2. micronizing, respectively above-mentioned each component is weighed and mix after be ground into 200 object fine powders, 3. soak, under the clear water room temperature of the medicated powder that is about to crush by 5 times of medicated powder weight, soak 3 hours, 4. medicinal liquid extracts, from soaked medicine liquid mixture by medicated powder residue and separating liquid medicine, leave and take medicinal liquid for subsequent use, 5. soak again, under the clear water room temperature by 5 times of former medicated powder weight, soak 3 hours again with the medicated powder residue after medicinal liquid extraction for the first time, 6. medicinal liquid extracts again, from for the second time soak medicine liquid mixture by medicated powder residue and separating liquid medicine, leave and take medicinal liquid for subsequent use, 7. microwave extraction, after mixing by the medicinal liquid of extracted twice, by microwave concentration technique, medicinal liquid is condensed into the concentrated solution of 1 times of former medicated powder weight, 8. filter, 9. add antiseptic, 10. subpackage.
Unit: g
Claims (2)
1. a Chinese medicine oral liquid for the treatment of duck viral hepatitis, is characterized in that: its crude drug is: Radix Isatidis 8～12g, Fructus Carthami tinctorii 8～12g, Herba Artemisiae Scopariae 8～12g, the Radix Astragali 8～12g, Pericarpium Citri Reticulatae 8～12g, Herba Schizonepetae 3～7g, Zornia diphylla (Linn.) Pers. 3～7g, Herba Phyllanthi Urinariae 3～7g, Radix Bupleuri 3～7g, Radix Saposhnikoviae 3～7g, Fructus Gardeniae 3～7g, Flos Lonicerae 3～7g, Fructus Forsythiae 3～7g, Ramulus Uncariae Cum Uncis 3～7g, Radix Glycyrrhizae 3～7g; Its processing technology is: 1. sorting, and 2. micronizing, 3. soaks, and 4. medicinal liquid extracts, and 6. 5. microwave extraction filters, and 7. adds antiseptic, 8. subpackage; Described sorting, remove the impurity in each component, described micronizing, respectively above-mentioned each component is weighed and mix after be ground into 200 object fine powders, described immersion, under the clear water room temperature of the medicated powder that is about to crush by 5 times of medicated powder weight, soak 3 hours, described medicinal liquid extracts, from soaked medicine liquid mixture by medicated powder residue and separating liquid medicine, leave and take medicinal liquid for subsequent use, described microwave extraction, the medicinal liquid that is about to extract is condensed into medicinal liquid by microwave concentration technique the concentrated solution of 1 times of former medicated powder weight; Isolated medicated powder residue after soaking is soaked 3 hours under the clear water room temperature by 5 times of former medicated powder weight again, and then from through secondary soak medicine liquid mixture by medicated powder residue and separating liquid medicine, leave and take medicinal liquid, secondary is left and taken to medicinal liquid and isolated medicinal liquid for the first time and more mixed medicinal liquid is condensed into after mixing the concentrated solution of 1 times of former medicated powder weight.
2. a kind of Chinese medicine oral liquid for the treatment of duck viral hepatitis according to claim 1, is characterized in that: its crude drug is: Radix Isatidis 10g, Fructus Carthami tinctorii 10g, Herba Artemisiae Scopariae 10g, Radix Astragali 10g, Pericarpium Citri Reticulatae 10g, Herba Schizonepetae 5g, Zornia diphylla (Linn.) Pers. 5g, Herba Phyllanthi Urinariae 5g, Radix Bupleuri 5g, Radix Saposhnikoviae 5g, Fructus Gardeniae 5g, Flos Lonicerae 5g, Fructus Forsythiae 5g, Ramulus Uncariae Cum Uncis 5g, Radix Glycyrrhizae 5g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310074388.5A CN103142735B (en) | 2013-03-09 | 2013-03-09 | Traditional Chinese medicine oral liquid for treating duck virus hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310074388.5A CN103142735B (en) | 2013-03-09 | 2013-03-09 | Traditional Chinese medicine oral liquid for treating duck virus hepatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103142735A CN103142735A (en) | 2013-06-12 |
| CN103142735B true CN103142735B (en) | 2014-07-23 |
Family
ID=48541244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310074388.5A Expired - Fee Related CN103142735B (en) | 2013-03-09 | 2013-03-09 | Traditional Chinese medicine oral liquid for treating duck virus hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103142735B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104645116A (en) * | 2015-03-11 | 2015-05-27 | 格特生物制药（天津）有限公司 | Traditional Chinese medicine oral liquid for treating duck viral hepatitis and preparation method of traditional Chinese medicine oral liquid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1277898B1 (en) * | 1995-08-03 | 1997-11-12 | Mendes Srl | USE OF BASIC AMINO ACIDS, OF ACYL DERIVATIVES OF BASIC AMINO ACIDS AND OF THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR DISEASE PROPHYLAXIS |
| CN1098089C (en) * | 1998-04-28 | 2003-01-08 | 天津市新迪亚医药新技术发展有限公司 | Medicine for treating hepatitis and liver fibrosis, and method for preparing same |
| CN1939454A (en) * | 2006-06-13 | 2007-04-04 | 天津生机集团有限公司 | Chinese medicinal composition for duck |
| CN101507779B (en) * | 2009-03-30 | 2011-06-08 | 席善根 | Chinese patent medicine for treating urgent, chronic viral hepatitis type B |
| KR20110014831A (en) * | 2009-08-06 | 2011-02-14 | 주식회사 청정해역 | Health as the basis for kelp food manufacturing |
| CN102640876B (en) * | 2012-05-22 | 2013-06-12 | 山东新希望六和集团有限公司 | Feed and injection used for treating duck virus hepatitis and preparation method of feed and injection |
| CN102813855B (en) * | 2012-09-12 | 2013-11-13 | 冯小明 | Chinese herbal preparation used for treating chronic viral hepatitis type b and taking method thereof |
-
2013
- 2013-03-09 CN CN201310074388.5A patent/CN103142735B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103142735A (en) | 2013-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103263059A (en) | Solid beverage for clearing away lung-heat, promoting diuresis, reducing phlegm and relieving cough and preparation method thereof | |
| CN102309606B (en) | Chinese medicinal oral liquid for treating chicken infectious proventriculitis | |
| CN101773569B (en) | Oral Chinese medicine liquid for treating chicken infectious laryngotracheitis | |
| CN102488778A (en) | Chinese traditional medicine preparation for treating upper respiratory tract infection of livestock and preparation method thereof | |
| CN102327378B (en) | Medicinal composition for preventing and treating porcine myocarditis | |
| CN103142735B (en) | Traditional Chinese medicine oral liquid for treating duck virus hepatitis | |
| CN102813712A (en) | Traditional Chinese medicine oral liquid for treating chicken coccidiosis | |
| CN103041051A (en) | Traditional Chinese medicine formula for treating acute mastitis | |
| CN101632766A (en) | Chinese medicinal composition for regulating menstruation and relieving pain | |
| CN103142731B (en) | Traditional Chinese medicine oral liquid for treating inclusion body hepatitis | |
| CN102247493A (en) | Chinese medicinal oral liquid capable of eliminating medicine resistance plasmid in chicken bacteria | |
| CN102000203A (en) | A traditional Chinese medicine for dispelling wind and eliminating dampness, promoting blood circulation and removing blood stasis | |
| CN105726628A (en) | Compound enteromorpha polysaccharide composition with anti-EV71 virus effect | |
| CN102247453B (en) | Chinese medicinal oral liquid for treating avian nephropathogenic infectious bronchitis | |
| CN103142775B (en) | Traditional Chinese medicine oral liquid for treating chicken pox | |
| CN102813723A (en) | Traditional Chinese medicine oral liquid for treating broiler ascites syndrome | |
| CN102240346B (en) | Chinese medicine oral solution for treating infectious bursal disease of chicken | |
| CN1063062C (en) | Chinese herbal medicine preparation for curing cerebral thrombosis | |
| CN101274058A (en) | Compound formulation of capsules for curing pulmonary tuberculosis with qi-blood deficiency syndrome and preparing technique | |
| CN106138879A (en) | A kind of cornus and cistanche wine | |
| CN101190302A (en) | Traditional Chinese medicine for treating trachitis | |
| CN105816740A (en) | Brain-tonifying liquor capable of eliminating dampness and phlegm | |
| CN103251693B (en) | Medicine for treating milky cow mastitis and preparation method | |
| CN103933499A (en) | Adult antidiarrheal and preparation method thereof | |
| CN104367798A (en) | Medicament for preventing and treating meat sheep pox and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 Termination date: 20150309 |
|
| EXPY | Termination of patent right or utility model |